Clinical Trials

Biliary Tract Neoplasms

NCT01286766 2024-12-27

Neoadjuvant Combination Chemotherapy of DCS and DCF in Patients With Locally Advanced Gastric Adenocarcinoma

6 enrolled

Phase 1 Active not recruiting

Stomach Neoplasms

NCT03252808 2024-12-09

Phase I Study of TBI-1401(HF10) Plus Chemotherapy in Patients with Unresectable Pancreatic Cancer.

36 enrolled

Pancreatic Neoplasms

NCT01285557 2024-09-19

DIGEST

Phase 3 Terminated

361 enrolled 18 charts

Stomach Neoplasms

NCT03382600 2024-06-11

KEYNOTE-659

100 enrolled 21 charts

Stomach Neoplasms

NCT04999332 2023-11-15

LOTS

58 enrolled

Stomach Neoplasms

NCT02191566 2022-12-08

SOHUG

Phase 2 Terminated

8 enrolled

Stomach Neoplasms

NCT00429858 2020-09-18

Gemcitabine and S-1 for Locally Advanced Unresectable or Metastatic Pancreatic Cancer

Phase 2 Terminated

21 enrolled 8 charts

Pancreatic Neoplasms

NCT01761461 2020-03-25

ARTIST-II

Phase 3 Unknown

547 enrolled

Stomach Neoplasms

NCT00915382 2020-01-07

Trial of 3-weekly Versus 5-weekly Schedule of S-1 Plus Cisplatin in Gastric Cancer: SOS

625 enrolled

Advanced Gastric Cancer

NCT02301481 2019-10-16

A Randomized Phase II Trial of Neoadjuvant Chemotherapy Compared With Chemoradiotherapy in Gastric Adenocarcinoma

71 enrolled

Stomach Neoplasms

NCT01283204 2019-01-29

Trial of 4-regimen (SP, FL/Tax, FL/Doc, FOLFOX) in Patients With Recurrent or Metastatic Gastric Cancer

180 enrolled

Recurrence, Stomach Neoplasms

NCT01815307 2018-05-16

Phase II Study of Gemcitabine Versus S-1 Adjuvant Therapy After Hemihepatectomy for Biliary Tract Cancer

70 enrolled

Biliary Tract Neoplasms

NCT01430052 2017-11-21

Chemoradiotherapy With Gemcitabine/S-1 vs Gemcitabine/S-1 for Locally Advanced Pancreatic Cancer

110 enrolled

Pancreatic Neoplasms

NCT03316326 2017-10-20

S-1, Irinotecan, and Oxaliplatin in Locally-Advanced Pancreatic Cancer

35 enrolled

Pancreatic Ductal Adenocarcinoma

NCT01693419 2017-08-23

S-1, Gemcitabine and Erlotinib for Advanced Pancreatic Cancer

37 enrolled

Pancreatic Neoplasms

NCT01693432 2017-08-23

Docetaxel and S-1 for Advanced Esophageal Cancer

37 enrolled

Esophageal Neoplasms

NCT02527785 2017-08-23

Study of Oxaliplatin, Irinotecan, and S-1 in Gastric Cancer

44 enrolled

Stomach Neoplasms

NCT03137004 2017-05-08

Docetaxel and S-1 Combination Therapy as Second-line Treatment for Advanced Gastric Cancer

47 enrolled

Advanced Gastric Cancer

NCT02870153 2016-08-19

SOX Versus XELOX for Patients With Peritoneal Metastasis of Colorectal Cancer

60 enrolled

Colorectal Neoplasms

NCT00660894 2016-08-03

Tegafur-Uracil and Leucovorin or S-1 in Treating Patients With Stage III Colon Cancer That Has Been Completely Removed by Surgery

1,535 enrolled

Colonic Neoplasms, Colorectal Neoplasms

NCT01100801 2016-06-22

3G

90 enrolled

Neoplasm Metastasis, Stomach Neoplasms

NCT01542294 2016-06-14

SOX as Adjuvant Chemotherapy for Resectable Gastric Cancer

Phase 1/2 Unknown

71 enrolled

Stomach Neoplasms

NCT01980810 2016-06-14

GC-A-003

Phase 2 Terminated

36 enrolled

Stomach Neoplasms

NCT00216034 2016-06-07

Randomized Controlled Study of Postoperative Adjuvant Therapy for Gastric Cancer Using TS-1 or TS-1+PSK

255 enrolled

Stomach Neoplasms

NCT02754180 2016-04-28

Adjuvant Gemcitabine Versus Gemcitabine With Chemoradiation in Pancreatic Adenocarcinoma With R1 Resection and/or Positive Lymph Nodes

110 enrolled

Pancreatic Neoplasms

NCT01693445 2016-02-19

S-1, Oxaliplatin, and Irinotecan for Advanced Gastrointestinal Cancer

22 enrolled

Gastrointestinal Neoplasms

NCT01671449 2015-11-30

SOPP

338 enrolled

Stomach Neoplasms

NCT01128998 2015-10-19

Sorafenib Plus S-1 in Advanced Solid Tumors

30 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT00438100 2015-05-29

Capecitabine vs. S-1 in Unresectable or Recurrent Breast Cancer

142 enrolled 4 charts

Breast

Breast Neoplasms

NCT01679340 2015-05-19

A PhaseⅡ Study: SOX vs SP in Adjuvant Chemotherapy After D2 Surgery

160 enrolled

Stomach Neoplasms

NCT01269216 2015-01-28

A Study of Neoadjuvant Chemoradiotherapy With 5-FU/Leucovorin (FL) vs. TS-1/Irinotecan in Patients With Locally Advanced Rectal Cancer

136 enrolled

Rectal Neoplasms

NCT01531452 2014-12-04

The Efficacy of Oxaliplatin Plus S-1 for Treatment of Gastric Cancer

43 enrolled

Stomach Neoplasms

NCT01291615 2014-10-23

Phase I Study of Gemcitabine or S-1 Adjuvant Therapy After Hemihepatectomy for Biliary Tract Cancer

6 enrolled

Biliary Tract Neoplasms

NCT02146703 2014-05-26

Gemcitabine and S-1 for Advanced Biliary Tract Cancer

38 enrolled

Biliary Tract Neoplasms

NCT00527930 2013-10-10

TORCH

87 enrolled

Breast

Breast Neoplasms

NCT01269255 2013-06-04

A Trial of Induction Chemotherapy and Chemoradiotherapy With TS-1 and Cisplatin (SP) as First-line Treatment in Patients With High Risk Advanced Gastric Cancer

6 enrolled

Stomach Neoplasms

NCT01824004 2013-04-04

Postoperative Chemoradiotherapy With S-1 in Gastric Cancer

46 enrolled

Stomach Neoplasms

NCT01492543 2013-03-15

Study of TS-1 as 2nd Line Treatment in Patients With Advanced Metastatic Breast Cancer

30 enrolled

Breast

Breast Neoplasms, Neoplasm Metastasis

NCT01747707 2012-12-12

Cisplatin,Docetaxel and S-1 for Advanced Gastric and Gastroesophageal Junction Cancer

40 enrolled

Stomach Neoplasms

NCT00284258 2012-11-02

Phase II/III Trial of CPT-11/5-FU/l-LV Versus CPT-11/TS-1 as Second Line Chemotherapy of Unresectable Colorectal Cancer

Phase 2/3 Completed

426 enrolled

Colorectal Neoplasms

NCT00498225 2012-11-02

GEST

834 enrolled

Pancreatic Neoplasms

NCT00677144 2012-10-05

Oxaliplatin and S-1 (OS) Versus Oxaliplatin and Capecitabine (XELOX) for Advanced Colorectal Cancer

88 enrolled

Colorectal Neoplasms

NCT00525005 2012-09-21

Docetaxel, Oxaliplatin and S-1 (DOS) for Advanced Gastric Cancer

44 enrolled

Stomach Neoplasms

NCT01645748 2012-07-20

TPSHNSCC

35 enrolled

Head & Neck

Head and Neck Neoplasms

NCT01608646 2012-05-31

Study of DPD for Predicting Efficacy and Safety to S-1 Plus Oxaliplatin in Gastrointestinal Cancer

200 enrolled

Gastrointestinal Neoplasms

NCT00687843 2012-03-22

TMOG-GC01

Phase 3 Unknown

480 enrolled

Stomach Neoplasms

NCT01533324 2012-02-15

S-1/LV One Week on and One Week Off Regimen in Advanced Hepatocellular Carcinoma (HCC)

32 enrolled

Carcinoma, Carcinoma, Hepatocellular, Liver Diseases

NCT01131689 2012-02-02

Trial of S-1 in Combination With Sorafenib for Patients With Advanced Hepatocellular Carcinoma

20 enrolled